Evaluation of the Tolerance of a New Formula Based on Hydrolyzed Rice Proteins in Children With Cow's Milk Allergy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age1-36
SponsorHealth and Happiness Research Limited

About this trial

The goal of this clinical trial is to see if a new formula based on hydrolysed rice proteins (Rice formula) is well tolerated by infants and young children with cow's milk allergy. In case the Rice formula is well tolerated, the formula will be considered " hypoallergenic ".

The main question it aims to answer is: Does the Rice formula cause allergic reactions in infants and young children who are allergic to cow's milk? Researchers will compare during a double-blind placebo-controlled food challenge (DBPCFC) the Rice formula to a Placebo formula to see if any allergic symptom appears after feeding with the Rice formula. If children do not show any allergic symptoms during the DBPCFC, they will then be exclusively formula-fed the Rice formula for 7 days.

Participants will:

* come at the hospital twice (around 7 days apart) for the DBPCFC * then, after this procedure, be fed the Rice formula for 7 days, as a replacement for their usual infant formula

Their parents will pay attention to the appearance of any allergic symptom after each day of the DBPCFC, and during the 7-day feeding period. They will keep a diary of any adverse event in their child, the use of any concomitant treatment, and the introduction in their child's diet of any new allergenic food. In addition, during the 7-day feeding period, they will report quantities of the Rice formula consumed, data on regurgitations/vomiting if any, stool consistency/frequency/colour and their satisfaction.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Infants and young children between 1 and 36 months of age

Consuming at least 240 ml/day of formula

Gestational age ≥ 37 weeks

Diagnosis of IgE-mediated CMA confirmed through a DBPCFC performed within 3 months prior to the enrolment

Disqualifiers

Infant is exclusively breastfed.

Any chronic diseases, chromosomal or major congenital anomalies (based on medical history and/or commonly performed diagnostic criteria).

Major gastrointestinal disease/abnormalities (other than CMA).

Other food allergies

Trial design

Design model

Crossover

Treatments tested in this trial

  • Rice formula (New formula based on hydrolysed rice proteins)

    Other intervention

    Infant formula based on hydrolysed rice proteins.

  • Placebo formula

    Other intervention

    The placebo formula will be the formula the subject is currently successfully fed with as part of his/her diet to eliminate cow's milk proteins.

Treatment groups

29 Participants
are divided into 2 treatment groups
Group A: DBPCFC = Day 1: Rice formula; Day 2: Placebo formulaExperimental treatment 2 interventions
Group B: DBPCFC = Day 1: Placebo formula; Day 2: Rice formulaExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Hypoallergenicity of the Rice formula

It will be assessed through the absence of medically confirmed allergic reaction to the study formula (Rice formula), based on assessment of clinical signs and symptoms at clinical DBPCFC testing and during the 7-day open feeding period.

Time frame
At the end of the 7-day open feeding period

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Health and Happiness Research Limited

Lead sponsor

Federico II University

Collaborator